Paper53329
Clinical and serological analysis of transfusion-associated hepatitis.
Alter HJ and 5 others. Lancet, 1975. Cited by 319 papers, by iCite.
Cite this record
ConductScience Library. Clinical and serological analysis of transfusion-associated hepatitis. Papers, record 53329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53329
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Transfusion Reaction | Major topic |
| Adult | |
| Alanine Transaminase | |
| Antibodies, Viral | |
| Aspartate Aminotransferases | |
| Bilirubin | |
| Blood Donors | |
| Blood Specimen Collection | |
| Cytomegalovirus | |
| Hemagglutination Tests | |
| Hepatitis B Antigens | |
| Hepatitis B virus | |
| Hepatovirus | |
| Herpesvirus 4, Human | |
| Humans | |
| Prospective Studies | |
| Radioimmunoassay |
Source PubMed
Cited by70
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 319 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42478159 | Direct-Acting Antiviral Therapy and Hepatocellular Carcinoma in Captive Chimpanzees With Long-Standing Chronic Hepatitis C Virus Infection. | J Med Virol | 2026 | https://conductscience.org/library/papers/42478159 | PubMed |
| 39205233 | Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico. | Viruses | 2024 | https://conductscience.org/library/papers/39205233 | PubMed |
| 37632090 | Discovery of Hepatitis E and Its Impact on Global Health: A Journey of 44 Years about an Incredible Human-Interest Story. | Viruses | 2023 | https://conductscience.org/library/papers/37632090 | PubMed |
| 37614826 | Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions. | Cureus | 2023 | https://conductscience.org/library/papers/37614826 | PubMed |
| 36680254 | Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review. | Viruses | 2023 | https://conductscience.org/library/papers/36680254 | PubMed |
| 35595834 | Breakthroughs in hepatitis C research: from discovery to cure. | Nat Rev Gastroenterol Hepatol | 2022 | https://conductscience.org/library/papers/35595834 | PubMed |
| 34578419 | The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research-Lessons in Scientific Community Outreach. | Viruses | 2021 | https://conductscience.org/library/papers/34578419 | PubMed |
| 34517450 | [Progress in prevention and control of viral hepatitis since the establishing of the People's Republic of China]. | Zhonghua Gan Zang Bing Za Zhi | 2021 | https://conductscience.org/library/papers/34517450 | PubMed |
| 34245922 | The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus. | Biomed J | 2021 | https://conductscience.org/library/papers/34245922 | PubMed |
| 33976895 | A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019. | New Microbes New Infect | 2021 | https://conductscience.org/library/papers/33976895 | PubMed |
| 33505148 | Human hepatitis viruses-associated cutaneous and systemic vasculitis. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/33505148 | PubMed |
| 33430338 | Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure. | Pathogens | 2021 | https://conductscience.org/library/papers/33430338 | PubMed |
| 33337581 | Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020. | Kaohsiung J Med Sci | 2021 | https://conductscience.org/library/papers/33337581 | PubMed |
| 33261650 | Hepatitis C: milestones from discovery to clinical cure. | Mil Med Res | 2020 | https://conductscience.org/library/papers/33261650 | PubMed |
| 32655240 | The Discovery of Hepatitis Viruses: Agents and Disease. | J Clin Exp Hepatol | 2020 | https://conductscience.org/library/papers/32655240 | PubMed |
| 30875640 | Taming a beast: lessons from the domestication of hepatitis C virus. | Curr Opin Virol | 2019 | https://conductscience.org/library/papers/30875640 | PubMed |
| 30593647 | Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30593647 | PubMed |
| 28824743 | Is the 25-year hepatitis C marathon coming to an end to declare victory? | World J Hepatol | 2017 | https://conductscience.org/library/papers/28824743 | PubMed |
| 27784846 | Hepatitis C Virus and Antiviral Drug Resistance. | Gut Liver | 2016 | https://conductscience.org/library/papers/27784846 | PubMed |
| 25463603 | NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release. | Virology | 2015 | https://conductscience.org/library/papers/25463603 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/53329
GET https://conductscience.org/api/papers/v1/53329/cited_by?page=2